✦ LIBER ✦

2097 ORAL Biomarker analysis of lapatinib with paclitaxel versus paclitaxel as first-line treatment in 580 patients with metastatic breast cancer

✍ Scribed by R.S. Finn; M.F. Press; J. Dering; H. Gomez; Z. Aziz; M. Arbushites; M. Koehler; C. Oliva; L.S. Williams; A. Di Leo

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lapatinib plus paclitaxel versus paclita

✍ Y. Wu; A. Segreti; D. Cella; A. DiLeo; M. Amonkar; M. Koehler; M. Arbushites; M. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Capecitabine and weekly paclitaxel as fi

✍ Imjai CHITAPANARUX; Pimkhuan KAMNERDSUPAPHON; Ekasit THARAVICHITKUL; Vicharn LOR 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB

PCN80 Comparative Analysis of Cost-Effec

✍ Arreola Ornelas, H.; Rosado Buzzo, A.; García, L.; Camacho, L.M.; Lechuga, D. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

Gemcitabine in Combination with Paclitax

✍ Denise A. Yardley 📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 40 KB

Gemcitabine in Combination with Paclitax

✍ Carlos Delfino 📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 38 KB

Gemcitabine in Combination with Paclitax

✍ Ramon Colomer 📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 39 KB